agilon health (NYSE:AGL – Get Free Report) had its price objective raised by stock analysts at Truist Financial from $6.40 to $6.50 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a “hold” rating on the stock. Truist Financial’s price objective suggests a potential upside of 6.73% from the stock’s previous close.
Several other equities analysts have also recently commented on the company. Royal Bank of Canada cut their price target on agilon health from $11.00 to $8.00 and set an “outperform” rating for the company in a report on Wednesday, February 28th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $6.50 price target (down previously from $25.00) on shares of agilon health in a report on Monday, February 26th. Evercore ISI cut their price target on agilon health from $7.00 to $6.00 and set an “in-line” rating for the company in a report on Wednesday, February 28th. Benchmark cut their price target on agilon health from $13.00 to $9.00 and set a “buy” rating for the company in a report on Thursday, February 29th. Finally, Citigroup began coverage on agilon health in a report on Monday, April 22nd. They issued a “neutral” rating and a $6.00 price target for the company. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $9.25.
View Our Latest Analysis on agilon health
agilon health Price Performance
NYSE AGL opened at $6.09 on Friday. agilon health has a twelve month low of $4.41 and a twelve month high of $21.52. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.33 and a current ratio of 1.33. The stock has a market capitalization of $2.50 billion, a PE ratio of -8.70 and a beta of 0.52. The stock has a 50-day simple moving average of $5.26 and a 200 day simple moving average of $7.70.
agilon health (NYSE:AGL – Get Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the prior year, the firm posted ($0.14) EPS. agilon health’s revenue for the quarter was up 71.8% on a year-over-year basis. Research analysts anticipate that agilon health will post -0.35 EPS for the current year.
Institutional Investors Weigh In On agilon health
Large investors have recently bought and sold shares of the business. Wellington Management Group LLP grew its position in agilon health by 8.3% during the 3rd quarter. Wellington Management Group LLP now owns 41,318,777 shares of the company’s stock worth $733,821,000 after acquiring an additional 3,162,094 shares during the last quarter. California Public Employees Retirement System grew its position in agilon health by 27.7% during the 3rd quarter. California Public Employees Retirement System now owns 413,987 shares of the company’s stock worth $7,352,000 after acquiring an additional 89,728 shares during the last quarter. Morgan Stanley grew its position in agilon health by 8.9% during the 3rd quarter. Morgan Stanley now owns 44,819,378 shares of the company’s stock worth $795,992,000 after acquiring an additional 3,674,311 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in agilon health by 4.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,796,884 shares of the company’s stock worth $31,913,000 after acquiring an additional 70,443 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its position in agilon health by 222.5% during the 3rd quarter. Tower Research Capital LLC TRC now owns 23,660 shares of the company’s stock worth $420,000 after acquiring an additional 16,324 shares during the last quarter.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Recommended Stories
Receive News & Ratings for agilon health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for agilon health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
